EUVIMEDEUVIMED entdecken
EditorialKommentar

In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication

Kimberly M Dickinson, Peter J Mogayzel

Journal of Cystic Fibrosis · 2023

DOI: 10.1016/j.jcf.2023.01.009 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von Kimberly M Dickinson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas Infections. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPseudomonas InfectionsHumansPseudomonas aeruginosaAnti-Bacterial AgentsTobramycin

Substanzen

Anti-Bacterial AgentsTobramycin

Autor:innen und Institutionen

  • Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
  • Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. Electronic address: mogayze@jhmi.edu.

Zitieren

APA

Dickinson, K. M., & Mogayzel, P. J. (2023). In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.01.009

Vancouver

Dickinson KM, Mogayzel PJ. In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.01.009

BibTeX
@article{Dickinson2023,
  author = {Dickinson, Kimberly M and Mogayzel, Peter J},
  title = {In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication},
  journal = {Journal of Cystic Fibrosis},
  year = {2023},
  doi = {10.1016/j.jcf.2023.01.009}
}
Kostenlos starten →